Kindling alters the anticonvulsant efficacy of phenytoin in Wistar rats

Epilepsy Research

Volumn 39, Issue 3, 2000, Pages 211-220

  Löscher, Wolfgang ^a   Reissmüller, Elke ^a   Ebert, Ulrich ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Anticonvulsant drugs; Epilepsy; Epileptogenesis; Fosphenytoin; Pharmacoresistance

Indexed keywords

FOSPHENYTOIN SODIUM; PHENYTOIN; PRODRUG;

AFTERDISCHARGE; AMYGDALOID NUCLEUS; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROENCEPHALOGRAM; FEMALE; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; ANTICONVULSANTS; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EPILEPSY; FEMALE; INDIVIDUALITY; KINDLING, NEUROLOGIC; PHENYTOIN; RATS; RATS, WISTAR; SEIZURES;

EID: 0342264691     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00100-5     Document Type: Article

References (26)

1. Albertson T., Peterson S., Stark L. Effects of phenobarbital and SC-13504 on partially kindled seizures in rats. Exp. Neurol. 61:1978;270-280.
2. Albertson T.E., Peterson S.L., Stark L.G. The anticonvulsant effects of diazepam and phenobarbital in prekindled and kindled seizures in rats. Neuropharmacology. 20:1981;597-603.
3. Albright P.S. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex. Exp. Neurol. 79:1983;11-17.
4. Cramer S., Ebert U., Löscher W. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: comparison of inbred strains. Epilepsia. 39:1998;1046-1053.
5. Ebert U., Cramer S., Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn Schmiedeberg's Arch. Pharmacol. 356:1997;341-347.
6. Ebert U., Rundfeldt C., Lehmann H., Löscher W. Characterization of phenytoin-resistant rats, a new model of drug-resistant partial epilepsy: influence of experimental and environmental factors. Epilepsy Res. 33:1999;199-215.
7. Ebert U., Löscher W. Characterization of phenytoin-resistant kindled rats, a new model of drug-resistant partial epilepsy: influence of genetic factors. Epilepsy Res. 33:1999;217-226.
8. Forsgren L. Epidemiology of intractable epilepsy in adults. Johannessen S.I., Gram L., Sillanpää M., Tomson T. Intractable Epilepsy. 1995;25-40 Wrightson Biomedical Publishing Ltd, Petersfield.
9. Freeman F.G., Jarvis M.F. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res. Bull. 7:1981;629-633.
10. Frey H.-H., Löscher W., Reiche R., Schultz D. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Pharmacology. 28:1984;329-335.
11. Hönack D., Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia. 36:1995;763-771.
12. Jurna I. Electrophysiological effects of antiepileptic drugs. Frey H.-H., Janz D. Antiepileptic Drugs. 1985;611-658 Springer, Berlin.
13. Löscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53:1997;239-258.
14. Löscher W., Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J. Pharmacol. Exp. Ther. 258:1991;483-489.
15. Löscher W., Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
16. Löscher W., Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17:1994;95-134.
17. Löscher W., Jäckel R., Czuczwar S.J. Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp. Neurol. 93:1986;211-226.
18. Löscher W., Rundfeldt C., Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res. 15:1993;207-219.
19. Löscher W., Cramer S., Ebert U. Selection of phenytoin responders and nonresponders in male and female amygdala-kindled Sprague-Dawley rats. Epilepsia. 39:1998a;1138-1147.
20. Löscher W., Cramer S., Ebert U. Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats. Epilepsy Res. 31:1998b;175-186.
21. Löscher W., Reissmüller E., Ebert U. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin. Epilepsy Res. 30:1998c;69-76.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. 1986;Academic Press, Sydney.
23. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
24. Rundfeldt C., Hönack D., Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 29:1990;845-851.
25. Smith R.D., Brown B.S., Maher R.W., Matier W.L. Pharmacology of ACC-9653 (phenytoin prodrug). Epilepsia. 30(Suppl. 2):1989;S15-S21.
26. Wilder B.J. Phenytoin-clinical use. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 4th edn. 1995;339-344 Raven Press, New York.